Tip:
Highlight text to annotate it
X
Hello and welcome to today's
episode of Hearing Review TV
your all access pass
to all things hearing.
Today's episode is brought to you by
the Audigy Group
the pre-eminent group of hearing providers
in North America.
I'm Jon Daugharthy.
College students learn some
In a study of 56 students
at the University of Florida
25 % of them did not have
normal hearing sensitivity.
This discovery was made during
another study at UF.
Researchers at the
College of Public Health and Health Professions
were recruiting students with normal hearing
for a study investigating hearing loss
and personal music players.
When the students showed up
for their initial hearing exam,
they found a quarter of the participants
measured 15 decibels or more
of hearing loss at one or more
of the test frequencies.
Of those who showed some hearing loss
7% had 25 decibels or more hearing loss.
The lead researcher is Colleen Leprell
an Associate Professor in the Department
of Speech, Language and Hearing at UF.
She says several experts have speculated
the increased rates of hearing loss
in young adults may be related to
personal music players, like iPods.
She says the highest level of hearing loss
was among the male students who reported
using personal music players.
She is now calling for more
thorough hearing tests in school children
and better hearing health education
for children and adolescents.
The Elite Hearing network is growing.
It recently added Starkey Laboratories
to its network product portfolio.
This brings the number
of hearing aid manufacturers in
Elite Hearing's network to eight.
Elite Hearing provides free membership
to independent hearing care providers
and offers comprehensive support
and product discounts to members.
Those services include free patient referrals,
financing options,
and a retirement savings plan.
The X-Factor
it's that something x-tra you get
when working for an
Audigy-certified practice.
You'll have a career
not just a job.
You'll receive support
from an expert team
of experienced professionals
investment in your continuing education
and professional growth
and, access to state-of-the-art
practice platforms
and cutting edge technology
Realize your personal,
professional, and financial goals.
Visit Audigy Group at
www.AudigyGroup.com
Discover the power the x-factor has in store for you!
Phase two of a clinical trial
designed to treat
acute inner ear tinnitus is underway.
Auris Medical is conducting the study
on a drug called AM101.
The main goal is to find
the optimum dosing level of the drug.
AM101 contains a small molecule
that selectively blocks
the NMDA receptors in the cochlea.
These receptors play a major role
in the occurrence of tinnitus
caused by a number of events.
Some of those include,
exposure to excessive noise,
disturbances to the inner ear blood supply,
migration of germs from the middle
ear to the inner ear,
middle ear surgery,
and certain ototoxic drugs.
The first phase of the trial
showed significant indicators
of the desired therapeutic effect.
Sonova makes a $94 million payment
to complete its purchase of InSound Medical.
In January of last year,
Sonova acquired InSound medical
for $75 million plus several
"earn out" payments based on
InSound's future financial success.
The recent payment
nullifies the original agreement.
Sonova says this buyout allows
the company to include InSound
in its US distribution plan
specifically for the
"lyric" hearing aid product line.
Lyric was the first 100 % invisible,
extended wear hearing device
that can be worn for up to 120 days.
The latest hearing device to come to the US
is so small, it's almost invisible.
Siemens Hearing Instruments is bringing
the iMini to the American market
It is already available in Europe.
The iMini is designed to fit deeper
in the ear than other aids,
but does not sacrifice comfort for invisibility,
because it sits in
the portion of the ear canal
that is made of bendable cartilage.
The iMini can be fine-tuned
to the preferences of each wearer
and features a speech and noise management system
that automatically reduces
background noise and enhances speech.
It is also available in a dozen colors.
HIMSA awards a much sought after
certification to Sycle Net.
This certification means
Sycle Net's software
has met all compatibility and performance requirements
under NOAH Standards.
NOAH is a hearing industry standard
for integrated hearing care software.
Sycle Net's marketing director is Peter Adams.
He says it's great that
HIMSA recognized the hard work
of the development team
with this stamp of approval.
He adds the Sycle NOAH Sync functionality
will bring many benefits to
the thousands of hearing care professionals
who use Sycle Net every day.
Sycle Net launched
the latest version of
its NOAH interface last year.
That's all we have for
today's episode of Hearing Review TV
brought to you by
the Audigy Group.
We'll see you next time.